Moteur de recherche d’entreprises européennes
Financement de l’UE (3 628 757 €) : Stress du réticulum endoplasmique dans la santé et la maladie Hor27/08/2015 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Stress du réticulum endoplasmique dans la santé et la maladie
Endoplasmic reticulum (ER) stress is emerging as a common feature in the pathology of numerous diseases including cancer, neurodegenerative disorders, metabolic syndromes and inflammatory diseases. Thus ER stress represents a potential therapeutic intervention point to be exploited to develop novel therapies, diagnostic tools and markers for these diseases. However, exploitation is hampered by the shortage of scientists with interdisciplinary training that can navigate with ease between the academic, industrial and clinical sectors, and that have the scientific and complementary skills, together with an innovative outlook, to convert research findings into commercial and clinical applications. This proposal will bring young researchers together with world-leading academics, clinicians and industry personnel, who are united in (1) their goal of forming a network of excellence aimed at understanding the ER stress response mechanistically and quantitatively and (2) applying this understanding to identify and validate the most suitable intervention points in order to provide innovative knowledge-driven strategies for the treatment of ER stress-associated diseases. The TRAIN-ERS network will provide early stage researchers (ESRs) with high quality scientific and complementary skills training combined with international, intersectoral work experience. This will produce highly trained, innovative, creative and entrepreneurial ESRs with greatly enhanced career prospects, who will continue to advance the state of the art in the Biomedical field in their further careers, and will confidently navigate at the interface of academic, clinical and private sector research. The TRAIN-ERS research programme will provide the ESR’s with the knowledge and the cutting edge scientific and technical skills that will drive our understanding and exploitation of the ER stress response for therapeutic and diagnostic purposes.
| BioScale Inc. | ? |
| Fundacio Institut D'Investigacio Biomedica de Bellvitge | 247 873 € |
| Goeteborgs Universitet | 263 659 € |
| Imperial College of Science Technology and Medicine | 273 288 € |
| Institut National de la Sante et de la Recherche Medicale | 525 751 € |
| JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN | 249 216 € |
| Katholieke Universiteit Leuven | 501 120 € |
| Ludwig Boltzmann Gesellschaft Osterreichische Vereinigung ZUR Forderung DER Wissenschaftlichen Forschung | 255 934 € |
| OPTIMATA Ltd. | 0,00 € |
| Randox Teoranta | 265 675 € |
| Royal College of Surgeons in Ireland | 0,00 € |
| University of Galway | 797 024 € |
| UNIVERSITY OF STUTTGART | 249 216 € |
https://cordis.europa.eu/project/id/675448
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Bioscale Inc., Lexington, États-Unis.
